Uncategorized

With the briefing in a federal lawsuit having concluded and Congress on the hunt for legislative savings, the question is when, not if, CMS’s minimum nurse staffing rule is killed, eliminating the overhang and potential…

At this early stage, we give tossup odds to Governor Mike DeWine’s (R-OH) budget proposal released yesterday, raising the state’s tax rate on sports betting from 20% to 40%, becoming law.  The budget now goes…

Both chambers of Congress are in session this week, but tariffs are likely to dominate the news flow. Meanwhile: Congressional leaders are trying to reach an agreement on FY25 spending levels. The House Budget Committees…

We continue to believe that President Trump will likely stick by his February 1 deadline for announcing 25% tariffs on Mexico and Canada for problems he sees at the border and fentanyl coming into the…

The four hours RFK spent with the Senate Finance Committee today bolsters our view that he is likely to be confirmed as HHS Secretary. Despite investor concerns with his antipathy for corporate medicine, we think…

We do not believe that the Trump administration will be successful in their attempts to freeze / cut federal funding that Congress authorized. However, we do see this attempt by the Trump administration as increasing…

We lean against yesterday’s OMB directive for temporarily pausing federal funding for grants, loans and programs applying largely to Medicaid’s payments to the states for Medicaid insurers (CNC, MOH, ELV, UNH, CVS) or for reimbursements…

We could see progress on a few fronts this week as Congress works on:   The massive reconciliation / tax bill legislation at a retreat starting today in Florida.  Top- line spending levels for defense and…

We have the following comments about President Trump’s recent trade pronouncements, which are generally consistent with our views before he became president. We are skeptical that the 25% tariffs on Mexico and Canada, in response…

While investors in insurers and providers seem most concerned about the fate of the expiring enhanced ACA subsidies, which we still expect to be revised but ultimately extended later this year, other – albeit smaller…